Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Three-Dimensional Quantitative Structure-Activity Relationships (3D-QSAR) on a Series of Piperazine-Carboxamides Fatty Acid Amide Hydrolase (FAAH) Inhibitors as a Useful Tool for the Design of New Cannabinoid Ligands.

Lorca M, Valdes Y, Chung H, Romero-Parra J, Pessoa-Mahana CD, Mella J.

Int J Mol Sci. 2019 May 21;20(10). pii: E2510. doi: 10.3390/ijms20102510.

PMID:
31117309
2.

Synthesis and biological evaluation of potential acetylcholinesterase inhibitors based on a benzoxazine core.

Méndez-Rojas C, Quiroz G, Faúndez M, Gallardo-Garrido C, Pessoa-Mahana CD, Chung H, Gallardo-Toledo E, Saitz-Barría C, Araya-Maturana R, Kogan MJ, Zúñiga-López MC, Iturriaga-Vásquez P, Valenzuela-Gutiérrez C, Pessoa-Mahana H.

Arch Pharm (Weinheim). 2018 May;351(5):e1800024. doi: 10.1002/ardp.201800024. Epub 2018 Apr 3.

PMID:
29611620
3.

2D-QSAR and 3D-QSAR/CoMSIA Studies on a Series of (R)-2-((2-(1H-Indol-2-yl)ethyl)amino)-1-Phenylethan-1-ol with Human β₃-Adrenergic Activity.

Apablaza G, Montoya L, Morales-Verdejo C, Mellado M, Cuellar M, Lagos CF, Soto-Delgado J, Chung H, Pessoa-Mahana CD, Mella J.

Molecules. 2017 Mar 5;22(3). pii: E404. doi: 10.3390/molecules22030404.

4.

Combined CoMFA and CoMSIA 3D-QSAR study of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.

Romero-Parra J, Chung H, Tapia RA, Faúndez M, Morales-Verdejo C, Lorca M, Lagos CF, Di Marzo V, David Pessoa-Mahana C, Mella J.

Eur J Pharm Sci. 2017 Apr 1;101:1-10. doi: 10.1016/j.ejps.2017.01.037. Epub 2017 Jan 28.

PMID:
28137469
5.

Synthesis and Docking of Novel 3-Indolylpropyl Derivatives as New Polypharmacological Agents Displaying Affinity for 5-HT1A R/SERT.

Pessoa-Mahana H, Silva-Matus P, Pessoa-Mahana CD, Chung H, Iturriaga-Vásquez P, Quiroz G, Möller-Acuña P, Zapata-Torres G, Saitz-Barría C, Araya-Maturana R, Reyes-Parada M.

Arch Pharm (Weinheim). 2017 Jan;350(1). doi: 10.1002/ardp.201600271. Epub 2016 Dec 16.

PMID:
27981607

Supplemental Content

Loading ...
Support Center